Biocon trades higher on the bourses

16 Jun 2014 Evaluate

Biocon is currently trading at Rs. 483.00, up by 1.80 points or 0.37% from its previous closing of Rs. 481.20 on the BSE.

The scrip opened at Rs. 480.00 and has touched a high and low of Rs. 491.55 and Rs. 476.00 respectively. So far 77466 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 513.65 on 21-Apr-2014 and a 52 week low of Rs. 267.70 on 14-Jun-2013.

Last one week high and low of the scrip stood at Rs. 509.80 and Rs. 458.20 respectively. The current market cap of the company is Rs. 9747.00 crore.

The promoters holding in the company stood at 60.97% while Institutions and Non-Institutions held 19.58% and 19.44% respectively.

Bristol-Myers Squibb, the NYSE listed global pharma major and Syngene International, the contract research subsidiary of India’s largest publicly held biotechnology company Biocon, have expanded their drug discovery and development collaboration in India for five more years.

Since 2007, Bristol-Myers Squibb has been working with Syngene and its corporate parent, Biocon, to develop integrated capabilities in medicinal and process chemistry, biology, biotechnology, biomarkers, drug metabolism and pharmacokinetics, analytical research, and pharmaceutical development at the Biocon Bristol-Myers Squibb Research Center (BBRC) in Bangalore.

The US-India collaboration has produced six drug candidates for further study and also helped Bristol-Myers Squibb reduce the time and costs associated with advancing new compounds to first-in-human studies. One drug candidate currently in clinical trials was discovered at BBRC and early nonclinical development work done at BBRC has enabled most of Bristol-Myers Squibb’s small molecule assets to advance to later stages of development over the last five years.

Biocon is India’s largest and Asia's leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×